Product
Oral risperidone
1 clinical trial
1 indication
Indication
SchizophreniaClinical trial
A Single Ascending Dose Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Single Intramuscular Injection of Quarterly Risperidone (QUAR) for Different Formulations and Dose Strengths in Participants With Schizophrenia (QUARTZ Study)Status: Recruiting, Estimated PCD: 2026-05-01